Inflammatory bowel disease is a diverse disease that affects people all over the globe. This diversity in setting and treatment options makes it difficult for researchers to estimate the exact cost of ...

Patients with acute kidney injury requiring temporary hemodialysis often follow the protocol used for people on long-term ...

At a Senate confirmation hearing for CMS administrator, Mehmet Oz, M.D., would not answer directly whether he would support ...

Lissy Hu, M.D., MBA, CEO of Ascend Learning, was one of Managed Healthcare Executive’s 2022 Emerging Leaders in Healthcare ...

Early research shows a one-time gene therapy has potential for addressing both the liver and lung disease that patients with ...

Data show people with pulmonary arterial hypertension tend to stay in the hospital longer and have higher medical bills.

David M. Cordani, chairman and CEO of The Cigna Group, expressed that these moves were made to “build upon our strengths for ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

The early results of trials for two injectable, investigational antiretroviral therapies, VH4524184 and VH4011499, have the ...

Celltrion has launched Steqeyma (ustekinumab-stba), its biosimilar of Stelara (ustekinumab), at list price at an 85% discount ...

In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...